NEONC TECHNOLOGIES HOLDINGS, INC. Increase (Decrease) in Prepaid Expense
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Increase (Decrease) in Prepaid Expense of $824.17 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was $173.37K.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was $650.80K, a 15.01% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was -$70.63K.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was -$82.97K, a 133.78% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in prepaid expense for fiscal 2025 was $196.53K, a 58.97% increase from fiscal 2024.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in prepaid expense for fiscal 2024 was $123.63K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $173.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $824.17K 10-Q · filed 2026-08-10 | $753.54K derived: sum of 3 quarters · filed 2026-08-10 | $670.57K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $650.80K 10-Q · filed 2026-05-15 | $580.17K derived: sum of 2 quarters · filed 2026-05-15 | $497.20K derived: sum of 3 quarters · filed 2026-05-15 | $81.60K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$70.63K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$153.60K derived: sum of 2 quarters · filed 2026-03-31 | -$569.20K derived: sum of 3 quarters · filed 2026-08-10 | $196.53K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$82.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$498.58K derived: sum of 2 quarters · filed 2026-08-10 | $267.16K 10-Q · filed 2025-11-14 | $54.87K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$415.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $350.13K 10-Q · filed 2026-08-10 | $137.84K derived: sum of 3 quarters · filed 2026-08-10 | $383.45K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $765.74K 10-Q · filed 2026-05-15 | $553.45K derived: sum of 2 quarters · filed 2026-05-15 | $799.05K derived: sum of 3 quarters · filed 2026-05-15 | $992.64K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$212.29K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $33.31K derived: sum of 2 quarters · filed 2026-03-31 | $226.90K derived: sum of 3 quarters · filed 2026-03-31 | $123.63K 10-K · filed 2026-03-31 |
| 2024-09-30 | $245.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $439.19K derived: sum of 2 quarters · filed 2025-11-14 | $335.92K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $193.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | $90.31K 10-Q · filed 2025-08-18 | ||
| 2024-03-31 | -$103.27K 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |